How would you identify and prioritize opportunities/indications with in solid tumors for the BRAF inhibitor in order to arrive at the most attractive 3-5 opportunities.
Answers
Answered by
0
BRAF mutations occur in more than 50% of melanoma patients, .... “ Multiple other solid organ tumors, such as lung or ..... Add to this the stress of our clinical work
Answered by
0
immune checkpoint inhibitors have been identified over ... He described some of the most interesting potential ... BRAF inhibition can lead to immune infiltration
Similar questions